Catalog record · Fraud Detection & AML
Stage as of Jun 9, 2026 · historical report, not live reconfirmation.
Project Guardian synthetic-opioid AML modeling
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 26, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Bank experiments with behavioral models for fentanyl and synthetic-opioid financial investigations.
- Reported stage
- Pilot
- Technology
- Machine Learning
- Business function
- Middle Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 26, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Article explicitly describes experimentation, not completed rollout. Status as of 2026-06-09.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Deployment evidence does not establish measured effectiveness or independently validated ROI.
Source register
- How Scotiabank is using AI to combat child exploitation | Perspectivesscotiabank.com · opens in a new tab
Scotiabank · issuer · full-text · Published 2026-06-09
Research lanes: north_america_banking · Batch global-discovery-2026-10-26. Coverage and remaining gaps